The antibody nomenclature follows the title of the corresponding search ... we used the name in the published literature as the standard. Furthermore, for antibody fragments lacking names in both the ...
Reactions were visualized by immunostaining with (top) anti-Ubiquitin antibody and (bottom ... (A) Schematic representation and nomenclature of RPE1 cell lines generated by CRISPR/Cas12a-mediated exon ...
Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...
Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection. But Scripps Research scientists have now discovered that for some HIV ...
In order to demonstrate the functionality of this concept, we have constructed a large human antibody single-chain fragment (scFv) library using these principles. This library has been ...
Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection. Scientists at Scripps Research have now made a new discovery for some ...
No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).
Therapeutic monoclonal antibodies have become molecules of choice to treat autoimmune disorders, inflammatory diseases, and cancer. Moreover, bispecific/multispecific antibodies that target more than ...
Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a condition of the nervous system that can be managed with lifestyle modifications or medications, depending on your individual needs.
Therapeutic monoclonal antibodies (mAbs ... In this review, introductory notes on the development and systematic nomenclature of therapeutic mAbs in general, set the stage for a detailed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results